Academic positions →
← Home OPEN CALLS

Research funding calls

All open calls for clinical and rehabilitation research found by our monitoring, from funders worldwide. Each call is checked against its official text; grouped by region and funding programme, sorted by deadline. Closed calls are removed automatically.

Open to Italian institutions

The official call explicitly allows organisations based in Italy (directly, as EU Member State, or as any country).

US Department of Defense – CDMRP 6

CDMRP – Parkinson’s Research Program (PRP)

DoW Parkinson's, Early Investigator Research Award

The Early Investigator Research Award supports early-career investigators in conducting innovative Parkinson's disease research. It offers two funding levels: Level 1 for fellows requiring a mentor, and Level 2 for early-career independent investigators requiring preliminary data. Eligible applicants include domestic and foreign public, private, for-profit, and nonprofit organizations. Proposed research must address specific Parkinson's disease focus areas and benefit military and civilian populations. Clinical trials are not allowed.

Eligible countries: Any country

Who can lead: Postdoctoral fellows, clinical fellows, or independent investigators within 10 years of advanced degree or residency training completion, or equivalent.

From the official call

“Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.”

Deadline 6 Nov 2026CLOSING SOON
Official call →

Letter of intent (required): 23 Oct 2026

CDMRP – Parkinson’s Research Program (PRP)

DoW Parkinson’s, Investigator-Initiated Research Award

The Investigator-Initiated Research Award supports highly rigorous, multidisciplinary, high-impact research projects addressing Parkinson's disease across basic science to clinical trials. Funded research must target at least one specific FY26 Parkinson's Research Program focus area and require preliminary data. Independent investigators at all academic levels affiliated with eligible domestic or foreign organizations can apply, with total costs capped at $2 million over a maximum three-year performance period.

Eligible countries: Any country

Who can lead: Independent investigators at all academic levels, or equivalent, affiliated with an eligible organization, regardless of ethnicity, nationality or citizenship s

From the official call

“Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.”

Deadline 6 Nov 2026CLOSING SOON
Official call →

Letter of intent (required): 23 Oct 2026

Defense Health Agency Spinal Cord Injury Research Program

Spinal Cord Injury Research Program Translational Research Award

The fiscal year 2026 Spinal Cord Injury Research Program Translational Research Award supports translational research that will accelerate the movement of promising ideas in spinal cord injury research into clinical applications. The call funds preclinical evaluations, clinical studies, and pilot trials addressing acute injury intervention, secondary health effects, psychosocial well-being, or rehabilitation. Eligible applicants include domestic and foreign, for-profit and nonprofit, public and private organizations. Proposals must name at least one spinal cord injury community partner.

Eligible countries: Any country

Who can lead: Independent investigators at all career levels can apply as Single PI. For Early-Career Partnership, at least one PI must be within 7 years of first faculty app

From the official call

“Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.”

Stage 1 deadline 12 Nov 2026CLOSING SOONtwo-stage call
Official call →
CDMRP – Spinal Cord Injury Research Program (SCIRP)

DoW Spinal Cord Injury, Clinical Trial Award

The fiscal year 2026 Spinal Cord Injury Research Program Clinical Trial Award supports the rapid implementation of clinical trials to significantly impact the treatment or management of spinal cord injury. Funding is available for single or partnering principal investigators, requiring at least two spinal cord community partners. Extramural and intramural organizations worldwide, including foreign and domestic, for-profit and nonprofit, are eligible to apply.

Eligible countries: Any country

Who can lead: Independent investigators at all career levels. For the partnership option, at least one PI must be an early-career investigator as specified.

From the official call

“Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.”

Deadline 12 Nov 2026CLOSING SOON
Official call →
CDMRP – Spinal Cord Injury Research Program (SCIRP)

DoW Spinal Cord Injury, Clinical Translation Research Award

The fiscal year 2026 Spinal Cord Injury Research Program Clinical Translation Research Award supports high-impact clinical research and clinical trials requiring preliminary studies to prepare for larger-scale implementation. The funding aims to accelerate the translation of interventions into clinical use and identify optimal diagnostic and treatment options. Eligible applicants include domestic and foreign organizations, and the call features an early-career partnership option and a requirement for community collaboration.

Eligible countries: Any country

Who can lead: Independent investigators at all career levels. For the Early-Career Partnership Option, at least one PI must be an early-career investigator.

From the official call

“Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.”

Stage 1 deadline 12 Nov 2026CLOSING SOONtwo-stage call
Official call →
CDMRP – Spinal Cord Injury Research Program (SCIRP)

DoW Spinal Cord Injury, Investigator-Initiated Research Award

The fiscal year 2026 Spinal Cord Injury Research Program Investigator-Initiated Research Award supports studies with the potential to contribute significantly to spinal cord injury research, patient care, and quality of life. It funds basic through translational science addressing specific programmatic goals. Eligible applicants include domestic and foreign organizations, both for-profit and non-profit. Independent investigators at all career levels may apply, with an optional early-career partnership pathway.

Eligible countries: Any country

Who can lead: Independent investigators at all career levels. For the Early-Career Partnership Option, at least one PI must be an early-career investigator.

From the official call

“Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities.”

Deadline 12 Nov 2026CLOSING SOON
Official call →

NIH – US National Institutes of Health 2

NIH – US National Institutes of Health

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

The NCMRR Early Career Research Award supports rehabilitation scientists in establishing independent research careers by funding basic or clinical research projects. The aim is to collect preliminary data for a subsequent R01 application. Eligible applicant organizations include higher education institutions, nonprofits, for-profit organizations, governments, and foreign organizations. Early-stage investigators who are no more than 8 years past their terminal degree may apply as lead investigators.

Eligible countries: Any country (non-US organisations eligible)

Who can lead: Must be an independent investigator, no more than 8 years beyond the date their terminal academic degree was awarded. Not a postdoctoral fellow at submission.

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.”

Next deadline 16 Feb 2027new applications
Official call →

Later deadlines: 16 Jun 2027, 16 Oct 2027 · Resubmissions: next 16 Nov 2026 · Call expires 8 Jan 2028

NIH – US National Institutes of Health

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

This funding opportunity invites investigator-initiated clinical trials addressing neurological diseases and disorders within the mission of the National Institute of Neurological Disorders and Stroke (NINDS). Supported projects include early- and middle-phase exploratory clinical trials as well as later-phase confirmatory Phase 3 or comparative effectiveness trials involving small molecules, biologics, devices, and behavioral or rehabilitation therapies across the lifespan. Various domestic and foreign organizational types are eligible to apply.

Eligible countries: Any country (non-US organisations eligible)

Who can lead: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.”

Deadline see official call
Official call →

Horizon Europe 4

Horizon Europe

Clinical trials for advancing innovative interventions for neurodegenerative diseases

This Horizon Europe call aims to support early-stage clinical trials evaluating the safety and efficacy of innovative, multi-disciplinary therapeutic interventions combined with complementary approaches for neurodegenerative diseases. Funded projects should improve patient quality of life, utilise health data according to FAIR principles, engage relevant stakeholders including patients, and leverage research infrastructures. Eligible applicants include international consortia composed of legal entities such as universities, clinical centres, and SMEs established in EU Member States or Associated Countries.

Eligible countries: EU Member States and associated countries

From the official call

“EU programme rules: legal entities established in EU Member States (including Italy) and associated countries are eligible.”

Looking for consortium partners? Search topic HORIZON-HLTH-2027-02-DISEASE-14-two-stage in the EU partner search, or see “Partner search announcements” on the call page.

Stage 1 deadline 17 Feb 2027two-stage call
Find partnersOfficial call →
Horizon EuropeDATES BEING CHECKED

Addressing disabilities through the life course to support independent living and inclusion

This Horizon Europe call aims to support research and innovation actions that promote independent living and inclusion for persons with long-term disabilities across their life-course. Funded projects will address health-related research, habilitation and rehabilitation services, disability prevention, and conditions for successful deinstitutionalisation. Eligible applicants include transnational consortia of researchers, healthcare providers, disability organisations, and other relevant bodies from EU Member States and associated countries.

Eligible countries: EU Member States and associated countries

From the official call

“EU programme rules: legal entities established in EU Member States (including Italy) and associated countries are eligible.”

Looking for consortium partners? Search topic HORIZON-HLTH-2027-01-STAYHLTH-01 in the EU partner search, or see “Partner search announcements” on the call page.

Deadline 17 Feb 2027
Find partnersOfficial call →
Horizon Europe – Cluster 1: Health

Innovative healthcare interventions for non-communicable diseases

This call aims to reduce the burden of specific non-communicable diseases such as cardiovascular diseases, diabetes, chronic respiratory diseases, or chronic kidney diseases. It supports rigorous early-stage clinical trials to validate novel or refined healthcare interventions, supported by completed proof-of-concept of clinical safety and efficacy. International consortia including universities, research institutions, hospitals, and SMEs can apply, incorporating digital technologies and social sciences and humanities.

Eligible countries: EU Member States and associated countries

From the official call

“EU programme rules: legal entities established in EU Member States (including Italy) and associated countries are eligible.”

Looking for consortium partners? Search topic HORIZON-HLTH-2027-02-DISEASE-01-two-stage in the EU partner search, or see “Partner search announcements” on the call page.

Stage 1 deadline 17 Feb 2027two-stage call
Find partnersOfficial call →
Horizon Europe – Cluster 1: Health

Prevention and management of chronic non-communicable diseases in children and young people (GACD)

This funding call supports implementation research exploring strategies and interventions for the prevention, diagnosis, screening, and management of chronic non-communicable diseases in individuals aged 1 to 24 living in low- and middle-income countries and/or underserved populations in high-income countries. It aims to fund multidisciplinary consortia including researchers, healthcare practitioners, and policymakers to deliver equitable, sustainable health interventions and build implementation research capacity.

Eligible countries: EU Member States and associated countries

From the official call

“EU programme rules: legal entities established in EU Member States (including Italy) and associated countries are eligible.”

Looking for consortium partners? Search topic HORIZON-HLTH-2027-01-DISEASE-10 in the EU partner search, or see “Partner search announcements” on the call page.

Deadline 17 Feb 2027
Find partnersOfficial call →

All other calls, by region

Grouped by where applicants can be based: international and intercontinental calls first, then each continent. Calls whose official text does not say where applicants can be based are listed under the funder's region.

International & intercontinental 3

Michael J. Fox Foundation 2

Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN)

Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN)

This funding program aims to support early career investigators whose Alzheimer's, Parkinson's, and related neurodegenerative research projects have been disrupted by changes or challenges in U.S. federal research funding. It funds salary and direct costs for projects facing delays, termination, priority misalignment, or funding gaps. Principal investigators must be early-stage investigators under NIH guidelines or within 7 years of their ESI designation, and host institutions must provide cost-sharing.

Eligible countries: Not stated in the official text: check the call

Who can lead: All Principal Investigators must be an early-stage investigator under the NIH guidelines or within 7 years of their ESI designation.

Next deadline 30 Oct 2026CLOSING SOONnew applications
Official call →

Later deadlines: 29 Jan 2027, 30 Apr 2027 · Letter of intent (required): 30 Oct 2026

Parkinson's Disease Therapeutics Pipeline Program

Parkinson's Disease Therapeutics Pipeline Program

This funding initiative accelerates Parkinson’s disease therapy development by funding pre-clinical and clinical development of disease-modifying or symptomatic interventions, as well as biomarker tools. Funding ranges from $250,000 to upwards of $5M for 1 to 3 years. The call is open to industry, academic/industry partnerships, and academic-led projects in certain cases. Applications follow a two-stage process with rolling pre-proposals and full proposals submitted by invitation.

Eligible countries: Not stated in the official text: check the call

Who can lead: Open to industry, academic/industry partnerships, and—in certain cases—academic-led projects.

Stage 1 deadline 30 Oct 2026CLOSING SOONtwo-stage call
Official call →

Later deadlines: 14 Jan 2027, 1 Apr 2027, 17 Jun 2027

ALS Association 1

ALS AssociationBEING CHECKED

AssistiveTech2026

Details are being checked against the official call.

Deadline 3 Nov 2026CLOSING SOON
Official call →

North America 11

NIH – US National Institutes of Health 7

NIH – US National Institutes of Health

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access

This funding opportunity solicits applications to conduct scientific research utilizing data from expanded access for investigational drugs or biological products. The research targets intermediate size populations of patients with amyotrophic lateral sclerosis who are ineligible for ongoing clinical trials. Eligible applicants are clinical trial sites participating in specific phase 2/3 or phase 3 efficacy clinical trials supported by an FDA-designated small business sponsor.

Eligible countries: United States only (foreign organisations not eligible)

Who can lead: Eligible applicants must be clinical trial sites that participate in a phase 2/3 or phase 3 efficacy clinical trial supported by an FDA-designated small busines

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.”

Deadline 10 Nov 2026CLOSING SOON
Official call →
NIH HEAL InitiativeCOMING SOON

HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers

This funding opportunity aims to renew the Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) research network, supporting individual research projects coordinated by a central center. The goal is to test improved approaches for individuals suffering from both chronic pain and opioid use disorder to enhance health system care delivery. Eligible applicants include domestic and foreign institutions, higher education, non-profits, tribal governments, and other specified organizations.

Eligible countries: Coming soon: published with the full call

Deadline 26 Jan 2027
Official call →
NIH – US National Institutes of Health

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

The National Institute on Aging offers support for established investigators to enhance aging and Alzheimer's Disease or related dementias research and educational capacity within their academic institution. The award funds research and educational infrastructure, mentorship, and career development activities such as courses, pilot funding, and travel awards. Applicants must be US-based established investigators holding a doctoral degree and a named PD/PI role on an active R01 or equivalent NIA grant.

Eligible countries: United States only (foreign organisations not eligible)

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.”

Next deadline 12 Feb 2027new applications
Official call →

Later deadlines: 12 Jun 2027, 12 Oct 2027 · Resubmissions: next 12 Nov 2026 · Call expires 13 Nov 2027

NIH – US National Institutes of Health

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

This NIH funding opportunity promotes the discovery and development of candidate biomarkers or composite biomarkers for neurological and neuromuscular disorders. The phased R61/R33 mechanism supports initial proof-of-concept studies and preliminary clinical validation to ensure biomarkers are fit for use in clinical trials or clinical practice. Eligible applicant organizations include domestic U.S. higher education institutions, nonprofits, for-profit entities, and government bodies. Foreign entities are not eligible to apply.

Eligible countries: United States only (foreign organisations not eligible)

Who can lead: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s).

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.”

Next deadline 22 Feb 2027new applications
Official call →

Later deadlines: 21 Jun 2027, 20 Oct 2027 · Resubmissions: next 22 Feb 2027 · Call expires 8 Jan 2028

NIH – US National Institutes of Health

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program

The National Institute on Aging supports summer research education programs for high school students, undergraduates, and science teachers to expand the Alzheimer's Disease and Alzheimer’s Disease-Related Dementias research workforce. Eligible applicant organizations include various U.S. higher education institutions, nonprofits, and government entities. The program offers intensive summer research experiences to encourage further study and careers in biomedical, behavioral, and clinical research.

Eligible countries: United States only (foreign organisations not eligible)

Who can lead: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s).

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.”

Next deadline 26 May 2027new applications
Official call →

Resubmissions: next 26 May 2027

NIH – US National Institutes of Health

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program

The National Institute on Aging (NIA) invites R25 applications to support research education programs for recent baccalaureates, aiming to expand the Alzheimer’s Disease and Related Dementias (AD/ADRD) research workforce. The program provides intensive mentored research experiences to prepare participants to transition into research-focused advanced degree programs or private sector careers. Eligible applicants include domestic higher education institutions, non-profits, and other eligible organizations in the United States. Independent clinical trials are not allowed.

Eligible countries: United States only (foreign organisations not eligible)

Who can lead: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s).

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.”

Next deadline 26 May 2027new applications
Official call →

Resubmissions: next 26 May 2027

NIH – US National Institutes of Health

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR)

The GEMSSTAR program aims to support early-career clinician-scientists in medical or surgical specialties to launch research careers focused on aging or geriatrics. It funds transdisciplinary pilot projects and professional development plans within supportive research environments. Only U.S.-based organizations are eligible to apply, as foreign organizations and foreign subawards are strictly excluded from this funding opportunity.

Eligible countries: United States only (foreign organisations not eligible)

Who can lead: Early-career clinician-scientists trained in medical or surgical specialties.

From the official call

“Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.”

Deadline see official call
Official call →

Foundation for Physical Therapy Research 1

Promotion of Doctoral Studies ScholarshipsON INSTAGRAM

Promotion of Doctoral Studies Scholarships

The Foundation for Physical Therapy Research offers scholarships supporting licensed physical therapists and physical therapist assistants who are APTA members and pursuing an academic doctoral degree with the intent to pursue a research career in physical therapy. The call provides funding for two phases: pre-candidates receive annual awards of $7,500 for coursework, while doctoral candidates receive $15,000 annually for the candidacy phase.

Eligible countries: Not stated in the official text: check the call

Who can lead: Licensed physical therapists and physical therapist assistants who are APTA members pursuing a PhD, EdD, DSc, or other academic doctoral degrees.

Deadline 20 Jan 2027
Official call →

U.S. National Science Foundation 1

U.S. National Science Foundation

Engineering Biological and Biomedical Systems (EBBS)

The Engineering Biological and Biomedical Systems program expands our understanding of biological and physiological systems to improve human health. It supports fundamental engineering research combining mechanistic insights with experimental and computational techniques to develop platforms, devices, tissues, and processes. Eligible applicants include a wide range of entities as specified by the funding agency, focusing on foundational discoveries rather than clinical trials or commercialization.

Eligible countries: Not stated in the official text: check the call

Deadline rolling, no fixed date
Official call →

Food and Drug Administration 2

Food and Drug Administration

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01)

This funding opportunity aims to support clinical trials evaluating the efficacy and safety of products to address unmet medical needs in rare neurodegenerative diseases for both children and adults. Funded through the R01 mechanism by the Food and Drug Administration, the initiative seeks to increase approved treatments and have a broad, positive impact on rare disease drug development. Eligible applicants include a wide variety of organizational types such as educational institutions, nonprofits, and for-profit entities.

Eligible countries: Not stated in the official text: check the call

Deadline see official call
Official call →
Food and Drug Administration

Studies Addressing Rare Neurodegenerative Diseases including ALS

This funding opportunity supports studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. The initiative aims to address critical knowledge gaps, make a significant impact on rare neurodegenerative diseases, and inform current or future product development. Various entity types, including governments, educational institutions, nonprofits, and for-profit organizations, are eligible to apply.

Eligible countries: Not stated in the official text: check the call

Deadline see official call
Official call →